Cargando…
Overcoming hypoxia-induced resistance of pancreatic and lung tumor cells by disrupting the PERK-NRF2-HIF-axis
Hypoxia-induced resistance of tumor cells to therapeutic treatment is an unresolved limitation due to poor vascular accessibility and protective cell adaptations provided by a network, including PERK, NRF2, and HIF signaling. All three pathways have been shown to influence each other, but a detailed...
Autores principales: | Küper, Alina, Baumann, Jennifer, Göpelt, Kirsten, Baumann, Melanie, Sänger, Christopher, Metzen, Eric, Kranz, Philip, Brockmeier, Ulf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806930/ https://www.ncbi.nlm.nih.gov/pubmed/33441543 http://dx.doi.org/10.1038/s41419-020-03319-7 |
Ejemplares similares
-
Tumor cells rely on the thiol oxidoreductase PDI for PERK signaling in order to survive ER stress
por: Kranz, Philip, et al.
Publicado: (2020) -
In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway
por: Ocklenburg, Tobias, et al.
Publicado: (2021) -
PDI is an essential redox-sensitive activator of PERK during the unfolded protein response (UPR)
por: Kranz, Philip, et al.
Publicado: (2017) -
Depletion of HIF-1α by Inducible Cre/loxP Increases the Sensitivity of Cultured Murine Hepatocytes to Ionizing Radiation in Hypoxia
por: Hamidi, Akram, et al.
Publicado: (2022) -
Depletion of the thiol oxidoreductase ERp57 in tumor cells inhibits proliferation and increases sensitivity to ionizing radiation and chemotherapeutics
por: Hussmann, Melanie, et al.
Publicado: (2015)